IP Verse

Cms Cameron Mckenna Nabarro Olswang patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Cms Cameron Mckenna Nabarro Olswang

Explore patent oppositions filed by Cms Cameron Mckenna Nabarro Olswang against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3770258
Modulation Of Ube3A-Ats ExpressionBAYLOR COLLEGE OF MEDICINEApr 16, 2025
EP3628319
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024
EP3542790
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024
EP3636778
Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)FRED HUTCHINSON CANCER CENTEROct 12, 2022
EP2863895
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 14, 2022
EP2350096
Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALSAug 6, 2020
EP3149481
Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1VENTANA MEDICAL SYSTEMSOct 9, 2019
EP2827845
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKSep 26, 2019
EP3111221
Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3VENTANA MEDICAL SYSTEMSJul 10, 2019
EP3009143
Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S DiseaseNEURODYN LIFE SCIENCESJul 3, 2019

Top competitors of Cms Cameron Mckenna Nabarro Olswang

Top competitors of Cms Cameron Mckenna Nabarro Olswang based on patent oppositions.